Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.

by Ashley P. Taylor

A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.

by Jon Kelvey

A new vaccine is safe for cancer patients but hard to find.

by Nancy Averett

Hormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women.

by Marilyn Fenichel

Organizations are testing new models of end-of-life care that allow patients to start hospice without stopping treatment.

by Cheryl Platzman Weinstock

The Cancer Today editorial staff selects some of the most interesting and impactful reporting, research and perspectives of 2018.

by Cancer Today Staff

Bob Riter explains how his breast cancer diagnosis set him on a path to find his calling.

by Bob Riter

High-intensity cancer caregiving is associated with poor mental health, especially for caregivers who don't feel they're getting the support services they need.

by Jen Tota McGivney

Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.

by Kate Yandell

Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.

by Anna Azvolinsky